Gene Editing Embryos Sparks Debate
The field of gene editing has witnessed significant advancements in recent years, with CRISPR-Cas9 being a major breakthrough. However, the latest development in this field has sparked a heated debate among scientists. Cathy Tie, a young entrepreneur, has launched Manhattan Genomics, a company that aims to edit the genomes of human embryos. This move reflects broader industry trends towards exploring the potential of gene editing in preventing genetic disorders. Tie’s company has already made some key hires, including a bioethicist and two scientists with expertise in non-human primate reproductive biology. The company plans to conduct extensive research and safety testing before attempting to create gene-edited babies. However, many scientists are worried that the technology is not yet mature, and the ethics, social consensus, and legal framework for its use are not yet in place. As Alexis Komor, a biochemist at the University of California San Diego, puts it, “The bar for safety is so, so, so, so high. We’re definitely not there yet.” ...